Browsing by Keyword : Bortezomib
Showing results 1 to 11 of 11
Pub Year | | Title | AJOU Author(s) |
2017 | | A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma | 박준성, 정성현 |
2014 | | Changes in osteoblastic activity in patient who received bortezomib as second line treatment for plasma cell myeloma: a prospective multicenter study | 박준성 |
2021 | | Crosstalk between HSPA5 arginylation and sequential ubiquitination leads to AKT degradation through autophagy flux | 김철호, 박준성, 정성현, 최용원 |
2016 | | Desensitization Using Bortezomib and High-dose Immunoglobulin Increases Rate of Deceased Donor Kidney Transplantation | 정종철 |
2023 | | Dual inhibition of thioredoxin reductase and proteasome is required for auranofin-induced paraptosis in breast cancer cells | 조미영, 최경숙 |
2022 | | ISRIB plus bortezomib triggers paraptosis in breast cancer cells via enhanced translation and subsequent proteotoxic stress | 최경숙 |
2019 | | Lercanidipine enhances the cytotoxicity of bortezomib in cancer cells by inducing paraptosis-associated cell death | 이아름, 최경숙 |
2019 | | Lercanidipine Synergistically Enhances Bortezomib Cytotoxicity in Cancer Cells via Enhanced Endoplasmic Reticulum Stress and Mitochondrial Ca(2+) Overload | 최경숙, 허훈 |
2019 | | Loperamide overcomes the resistance of colon cancer cells to bortezomib by inducing CHOP-mediated paraptosis-like cell death | 최경숙, 최용원 |
2017 | | Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis | 김인영, 최경숙 |
2022 | | PSMD14 Targeting Triggers Paraptosis in Breast Cancer Cells by Inducing Proteasome Inhibition and Ca2+ Imbalance | 강호철, 최경숙 |
1